- Home
- CEE vs MBOT Comparison
CEE vs MBOT Comparison
Compare CEE & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CEE | MBOT |
|---|---|---|
| Founded | 1990 | 2010 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.3M | 135.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CEE | MBOT |
|---|---|---|
| Price | $19.21 | $1.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.75 |
| AVG Volume (30 Days) | 22.0K | ★ 1.2M |
| Earning Date | 01-01-0001 | 03-24-2026 |
| Dividend Yield | ★ 3.86% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3,119.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.80 | $1.25 |
| 52 Week High | $10.32 | $4.67 |
Technical Indicators
Market Signals| Indicator | CEE | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 61.53 | 32.50 |
| Support Level | $19.10 | $1.60 |
| Resistance Level | $19.50 | $2.21 |
| Average True Range (ATR) | 0.56 | 0.10 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 89.20 | 15.71 |
Price Performance
Historical ComparisonAbout CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.